WPE_6899_460x337.jpg

Neurologie / Psychiatrie

Sie befinden sich hier:

Neurologie / Psychiatrie

Autor Titel/Link Jahr Journal
Becher et al. Cytokine networks in neuroinflammation. 2017 Nature reviews. Immunology
McGill et al. Acute bacterial meningitis in adults. 2017 Lancet (London, England)
Ramsden Multiple sclerosis: assay of free immunoglobulin light chains. 2017 Annals of clinical biochemistry
Aguzzi and Altmeyer Phase Separation: Linking Cellular Compartmentalization to Disease. 2016 Trends in cell biology
Aguzzi and Lakkaraju Cell Biology of Prions and Prionoids: A Status Report. 2016 Trends Cell Biol
Beneke et al. Differenzierung thrombotischer Mikroangiopathien 2016 Der Nephrologe
Costa and de Carvalho Emerging molecular biomarker targets for amyotrophic lateral sclerosis. 2016 Clin Chim Acta
Esenwa and Elkind Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. 2016 Nature reviews. Neurology
Gaiteri et al. Genetic variants in Alzheimer disease - molecular and brain network approaches. 2016 Nature reviews. Neurology
Gilhus Myasthenia Gravis. 2016 The New England journal of medicine
Gilhus et al. Myasthenia gravis - autoantibody characteristics and their implications for therapy. 2016 Nat Rev Neurol
Jarosz-Griffiths et al. Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. 2016 J Biol Chem
Kircheis and Häussinger Hepatische Enzephalopathie 2016 Der Gastroenterologe
Luo et al. Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis. 2016 The Journal of biological chemistry
Olsson et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. 2016 The Lancet. Neurology
Postuma and Berg Advances in markers of prodromal Parkinson disease. 2016 Nature reviews. Neurology
Scheltens et al. Alzheimer's disease. 2016 Lancet (London, England)
Schwartz and Deczkowska Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation. 2016 Trends in immunology
Sestan-Pesa and Horvath Metabolism and Mental Illness. 2016 Trends Mol Med
Spina et al. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 2016 Pharmacol Res
Vinik CLINICAL PRACTICE. Diabetic Sensory and Motor Neuropathy. 2016 N Engl J Med
Volkow et al. Neurobiologic Advances from the Brain Disease Model of Addiction. 2016 N Engl J Med
Wijdicks Hepatic Encephalopathy. 2016 The New England journal of medicine
Xue-Shan et al. Imbalanced cholesterol metabolism in Alzheimer's disease. 2016 Clin Chim Acta
Zetterberg and Blennow Fluid biomarkers for mild traumatic brain injury and related conditions. 2016 Nature reviews. Neurology
Beriault et al. Biomarkers, assays, and therapies for Alzheimer disease. 2015 Clin Chem
Bros et al. Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications. 2015 Clin Chem Lab Med
Chow and Gu The molecular constituents of the blood-brain barrier. 2015 Trends Neurosci
Dendrou et al. Immunopathology of multiple sclerosis. 2015 Nat Rev Immunol
De Deyn Dementia: Cerebrospinal fluid biomarkers in dementias. 2015 Nat Rev Neurol
Ellul et al. Hepatic encephalopathy due to liver cirrhosis. 2015 BMJ (Clinical research ed.)
Fourier et al. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability. 2015 Clin Chim Acta
Frake et al. Autophagy and neurodegeneration. 2015 J Clin Invest
Guo and Vander Kooi Neuropilin Functions as an Essential Cell Surface Receptor. 2015 J Biol Chem
Heni et al. Impaired insulin action in the human brain: causes and metabolic consequences. 2015 Nat Rev Endocrinol
Hess et al. Remote ischaemic conditioning-a new paradigm of self-protection in the brain. 2015 Nat Rev Neurol
Höglund et al. Alzheimer's disease – Recent biomarker developments in relation to updated diagnostic criteria. 2015 Clin Chim Acta
Holt and Mitchell Diabetes mellitus and severe mental illness: mechanisms and clinical implications. 2015 Nat Rev Endocrinol
Kalia and Lang Parkinson's disease. 2015 Lancet
Klingelhoefer and Reichmann Pathogenesis of Parkinson disease – the gut-brain axis and environmental factors. 2015 Nat Rev Neurol
Koedel et al. Lyme neuroborreliosis-epidemiology, diagnosis and management. 2015 Nat Rev Neurol
Kopf Diabetes mellitus und Demenz 2015 Internist (Berl)
Lleó et al. Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases. 2015 Nat Rev Neurol
Lobmann Neuropathie und diabetisches Fußsyndrom 2015 Internist (Berl)
Lu et al. Kidney-brain crosstalk in the acute and chronic setting. 2015 Nat Rev Nephrol
Lv et al. Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. 2015 Clin Chim Acta
Ma et al. Insulin resistance and cognitive dysfunction. 2015 Clin Chim Acta
Martinez and O'Driscoll Neuromedin U: a multifunctional neuropeptide with pleiotropic roles. 2015 Clin Chem
McQuail et al. Molecular aspects of age-related cognitive decline: the role of GABA signaling. 2015 Trends Mol Med
Min et al. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. 2015 Nat Med
Ordovas-Montanes et al. The Regulation of Immunological Processes by Peripheral Neurons in Homeostasis and Disease. 2015 Trends Immunol
Ptáček Episodic disorders: channelopathies and beyond. 2015 Annu Rev Physiol
Sancesario and Bernardini How many biomarkers to discriminate neurodegenerative dementia? 2015 Crit Rev Clin Lab Sci
Shine et al. Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data. 2015 Lancet
Tarasoff-Conway et al. Clearance systems in the brain-implications for Alzheimer disease. 2015 Nat Rev Neurol
Teunissen et al. Body fluid biomarkers for multiple sclerosis – the long road to clinical application. 2015 Nat Rev Neurol
Westphal and Lamszus Circulating biomarkers for gliomas. 2015 Nat Rev Neurol
Yu et al. High levels of serum mannose-binding lectins are associated with the severity and clinical outcomes of severe traumatic brain injury. 2015 Clin Chim Acta